{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:03:19Z","timestamp":1778216599217,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"am","delay-in-days":285,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["RO1 CA234025"],"award-info":[{"award-number":["RO1 CA234025"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F99-CA253731"],"award-info":[{"award-number":["F99-CA253731"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA283859"],"award-info":[{"award-number":["R35CA283859"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["RO1CA265333"],"award-info":[{"award-number":["RO1CA265333"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["RO1CA258746"],"award-info":[{"award-number":["RO1CA258746"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1DKO71909"],"award-info":[{"award-number":["RO1DKO71909"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canlet.2025.217738","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:18:26Z","timestamp":1745925506000},"page":"217738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A necrosis inducer promotes an immunogenic response and destroys ovarian cancers in mouse xenografts and patient ascites organoids"],"prefix":"10.1016","volume":"625","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0672-4651","authenticated-orcid":false,"given":"Darjan","family":"Duraki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1668-6548","authenticated-orcid":false,"given":"Musarrat","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4610-7278","authenticated-orcid":false,"given":"Chengjian","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7201-2498","authenticated-orcid":false,"given":"Santanu","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8616-2893","authenticated-orcid":false,"given":"Xinyi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5075-6619","authenticated-orcid":false,"given":"Junyao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2116-1167","authenticated-orcid":false,"given":"Matthew W.","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8887-1905","authenticated-orcid":false,"given":"Erik R.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9018-3581","authenticated-orcid":false,"given":"Paul J.","family":"Hergenrother","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8999-6750","authenticated-orcid":false,"given":"Georgina","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-6843","authenticated-orcid":false,"given":"David J.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217738_bib1","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.21873\/anticanres.15111","article-title":"Multimodal treatment of primary advanced ovarian cancer","volume":"41","author":"Friedrich","year":"2021","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2025.217738_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/GCO.0000000000000340","article-title":"Pathogenesis and heterogeneity of ovarian cancer","volume":"29","author":"Kroeger","year":"2017","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.canlet.2025.217738_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrclinonc.2015.224","article-title":"Can advanced stage ovarian cancer be cured?","volume":"13","author":"Narod","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217738_bib4","first-page":"561","article-title":"Ovarian cancer: an overview","volume":"91","author":"Penny","year":"2020","journal-title":"Radiol. Technol."},{"key":"10.1016\/j.canlet.2025.217738_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43018-020-00166-5","article-title":"Advances in ovarian cancer, from biology to treatment","volume":"2","author":"McMullen","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2025.217738_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","author":"Tan","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2025.217738_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217738_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217738_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.217738_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcancer.2021.08.011","article-title":"Chemotherapy resistance in epithelial ovarian cancer: mechanisms and emerging treatments","volume":"77","author":"Marchetti","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217738_bib11","doi-asserted-by":"crossref","first-page":"viii13","DOI":"10.1093\/annonc\/mdx446","article-title":"Acquired chemotherapy resistance in ovarian cancer","volume":"28","author":"Christie","year":"2017","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217738_bib12","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2025.217738_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s11523-023-00970-w","article-title":"PARP inhibitors in ovarian cancer: a review","author":"O'Malley","year":"2023","journal-title":"Target. Oncol."},{"issue":"29","key":"10.1016\/j.canlet.2025.217738_bib14","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1038\/onc.2014.292","article-title":"Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor \u03b1 positive breast cancer","volume":"34","author":"Andruska","year":"2015","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.canlet.2025.217738_bib15","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1073\/pnas.1403685112","article-title":"An estrogen receptor \u03b1 inhibitor activates the unfolded protein response, blocks protein synthesis and induces tumor regression","volume":"112","author":"Andruska","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2025.217738_bib16","article-title":"Antiestrogen resistant cell lines expressing estrogen receptor \u03b1 mutations upregulate the unfolded protein response and are killed by BHPI","author":"Mao","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.canlet.2025.217738_bib17","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41418-018-0143-2","article-title":"Strong and sustained activation of the anticipatory unfolded protein response induces necrotic cell death","volume":"25","author":"Livezey","year":"2018","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.canlet.2025.217738_bib18","article-title":"Src couples estrogen receptor to the anticipatory unfolded protein response and regulates cancer cell fate under stress","volume":"1867","author":"Yu","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res Oct"},{"key":"10.1016\/j.canlet.2025.217738_bib19","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.18632\/oncotarget.10819","article-title":"Targeting multidrug resistant ovarian cancer through estrogen receptor \u03b1 dependent hyperactivation of the UPR","volume":"9","author":"Zheng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217738_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf1383","article-title":"A small molecule activator of the unfolded protein response eradicates human breast tumors in mice","author":"Boudreau","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.canlet.2025.217738_bib21","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1021\/acs.jmedchem.1c01730","article-title":"Activators of the anticipatory unfolded protein response with enhanced selectivity for estrogen receptor positive breast cancer","volume":"10","author":"Boudreau","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2025.217738_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00325","article-title":"A new role for estrogen receptor \u03b1 in cell proliferation and cancer: activating the anticipatory unfolded protein response","author":"Livezey","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"18","key":"10.1016\/j.canlet.2025.217738_bib23","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1158\/0008-5472.CAN-23-0157","article-title":"Plasma membrane channel TRPM4 mediates immunogenic therapy-induced necrosis","volume":"83","author":"Ghosh","year":"2023","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2025.217738_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046858","article-title":"Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant tumors","volume":"7","author":"Latifi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217738_bib25","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.celrep.2015.10.042","article-title":"A small molecule that induces intrinsic pathway apoptosis with unparalleled speed","volume":"13","author":"Palchaudhuri","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.217738_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.canlet.2018.10.041","article-title":"Estrogen-independent myc overexpression confers endocrine therapy resistance on breast cancer cells expressing ER\u03b1Y537S and ER\u03b1D538G mutations","volume":"442","author":"Yu","year":"2019","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.canlet.2025.217738_bib27","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3390\/cancers16050932","article-title":"PARP inhibitors: strategic use and optimal management in ovarian cancer","volume":"16","author":"Hirschl","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"21","key":"10.1016\/j.canlet.2025.217738_bib28","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-10-1238","article-title":"Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastases. 2010","volume":"70","author":"Spillman","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217738_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2867-9-4","article-title":"Resistance to cisplatin does not affect sensitivity of human ovarian cancer cells to mifepristone cytotoxicity","author":"Freeburg","year":"2009","journal-title":"Cancer Cell Int."},{"issue":"8","key":"10.1016\/j.canlet.2025.217738_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081823","article-title":"Necroptosis in immuno-oncology and cancer immunotherapy","volume":"9","author":"Sprooten","year":"2020","journal-title":"Cells"},{"issue":"16","key":"10.1016\/j.canlet.2025.217738_bib31","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.7314\/APJCP.2015.16.16.7261","article-title":"Shikonin induced necroptosis via reactive oxygen species in the T-47D breast cancer cell line","volume":"16","author":"Shahsavari","year":"2015","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"4","key":"10.1016\/j.canlet.2025.217738_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.33594\/000000242","article-title":"Protein-bound polysaccharides from coriolus versicolor induce RIPK1\/RIPK3\/MLKL-mediated necroptosis in ER-positive breast cancer and amelanotic melanoma cells","volume":"54","author":"Pawlikowska","year":"2020","journal-title":"Cell. Physiol. Biochem."},{"issue":"12","key":"10.1016\/j.canlet.2025.217738_bib33","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2025.217738_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/2159-8290.CD-20-0789","article-title":"Modes of regulated cell death in cancer","volume":"11","author":"Koren","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.217738_bib35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcancer.2021.08.011","article-title":"Chemotherapy resistance in epithelial ovarian cancer: mechanisms and emerging treatments","volume":"77","author":"De Felice","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217738_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.semcancer.2020.08.017","article-title":"Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer","volume":"77","author":"Le Saux","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217738_bib37","article-title":"Immunotherapy and the ovarian cancer microenvironment: exploring potential strategies for enhanced treatment efficacy","author":"Ang","year":"2024","journal-title":"Immunology"},{"issue":"23","key":"10.1016\/j.canlet.2025.217738_bib38","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1056\/NEJMoa2309169","article-title":"Van gorp, t and gynecology Oncology group partners and the European network of gynaecological oncological trial groups","volume":"389","author":"Moore","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.canlet.2025.217738_bib39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","article-title":"ESR1 mutations \u2013 a mechanism for acquired endocrine resistance in breast cancer","volume":"12","author":"Jeselsohn","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217738_bib40","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41586-023-05755-9","article-title":"MEN1 mutations mediate clinical resistance to menin inhibition","volume":"615","author":"Perner","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217738_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-05912-0","article-title":"The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells","volume":"616","author":"Sen Santara","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.canlet.2025.217738_bib42","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41418-021-00878-w","article-title":"Single-cell derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer","volume":"29","author":"Velletri","year":"2022","journal-title":"Cell Death Differ."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:06:57Z","timestamp":1777550817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525003040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"alternative-id":["S0304383525003040"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217738","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A necrosis inducer promotes an immunogenic response and destroys ovarian cancers in mouse xenografts and patient ascites organoids","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217738"}}